PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,951,939 | +456.1% | 1,295,104 | +467.0% | 0.38% | +569.6% |
| Q2 2023 | $1,429,847 | -28.3% | 228,410 | -45.4% | 0.06% | -36.4% |
| Q1 2023 | $1,993,989 | -31.3% | 418,027 | +25.3% | 0.09% | -15.4% |
| Q4 2022 | $2,903,329 | -71.5% | 333,716 | -61.0% | 0.10% | -71.7% |
| Q3 2022 | $10,176,000 | -41.2% | 855,164 | -29.6% | 0.37% | -44.2% |
| Q2 2022 | $17,302,000 | +86.2% | 1,214,164 | +172.1% | 0.66% | +90.2% |
| Q1 2022 | $9,292,000 | +39.5% | 446,300 | +54.8% | 0.35% | +52.9% |
| Q4 2021 | $6,661,000 | -22.5% | 288,334 | 0.0% | 0.23% | -10.3% |
| Q3 2021 | $8,592,000 | -12.8% | 288,334 | 0.0% | 0.25% | -18.1% |
| Q2 2021 | $9,849,000 | – | 288,334 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |